Image of Josh Tumelty
Jury

Josh Tumelty
EVP, Executive Creative Director
Razorfish Health

PHILADELPHIA, USA // Early in Josh’s career he cut his creative teeth at Havas Worldwide (Formerly Euro RSCG) and quickly moved through the ranks from Designer to Senior Art Director — accumulating over a dozen creative awards during his first 3 years in the industry. From there he would go on to become the creative lead for an independent interactive and branding agency, focused on healthcare technology. Shortly after, Josh’s continued creative success opened the door to a coveted opportunity with Saatchi & Saatchi Healthcare and the Publicis Health network. More recently, Josh played a critical role in the integration of 3 agencies into a single unified brand specializing in purpose-driven marketing for high-science, highly complex categories.

His passion and unwavering commitment to deliver creativity without compromise has helped lead to the inception of more meaningful brand experiences for his clients. This passion, coupled with his own creative curiosity, has awarded Josh the opportunity to gain a wide range of industry experience, from global launches to first-in-class compounds, to working with rare forms of cancer.

Currently serving as the Executive Creative Director of Razorfish Health (New York, Chicago and Philadelphia), Josh believes strongly in the untapped creative potential that exists at the intersection of science and technology. And he’s proud to be a part of the new Razorfish Health which was recognized by Medical Marketing and Media as one of the Top 100 Healthcare Marketing and Advertising Agencies.

None of Josh’s success would be possible without the tremendous talent that has supported him and the partnerships he’s forged with some of the industry’s top clients, such as: Abbott Nutrition, Agilent Technologies, AstraZeneca Oncology, Athena Diagnostics, GlaxoSmithKline, Genentech, IMS Health, Novartis Oncology, Pfizer, Sanofi, Sanofi Pasteur, and Stryker Orthopaedics, Medical and Surgical equipment.